104 related articles for article (PubMed ID: 18604658)
1. Targeted delivery of doxorubicin via estrone-appended liposomes.
Rai S; Paliwal R; Vaidya B; Khatri K; Goyal AK; Gupta PN; Vyas SP
J Drug Target; 2008 Jul; 16(6):455-63. PubMed ID: 18604658
[TBL] [Abstract][Full Text] [Related]
2. A novel cancer targeting approach based on estrone anchored stealth liposome for site-specific breast cancer therapy.
Paliwal SR; Paliwal R; Mishra N; Mehta A; Vyas SP
Curr Cancer Drug Targets; 2010 May; 10(3):343-53. PubMed ID: 20370682
[TBL] [Abstract][Full Text] [Related]
3. Estrogen-anchored pH-sensitive liposomes as nanomodule designed for site-specific delivery of doxorubicin in breast cancer therapy.
Paliwal SR; Paliwal R; Pal HC; Saxena AK; Sharma PR; Gupta PN; Agrawal GP; Vyas SP
Mol Pharm; 2012 Jan; 9(1):176-86. PubMed ID: 22091702
[TBL] [Abstract][Full Text] [Related]
4. Targeted delivery of an anti-cancer agent via steroid coupled liposomes.
Mishra PK; Gulbake A; Jain A; Vyas SP; Jain SK
Drug Deliv; 2009 Nov; 16(8):437-47. PubMed ID: 19839788
[TBL] [Abstract][Full Text] [Related]
5. Estrogen-functionalized liposomes grafted with glutathione-responsive sheddable chotooligosaccharides for the therapy of osteosarcoma.
Yin X; Feng S; Chi Y; Liu J; Sun K; Guo C; Wu Z
Drug Deliv; 2018 Nov; 25(1):900-908. PubMed ID: 29644882
[TBL] [Abstract][Full Text] [Related]
6. Ultrasonically controlled estrone-modified liposomes for estrogen-positive breast cancer therapy.
Salkho NM; Paul V; Kawak P; Vitor RF; Martins AM; Al Sayah M; Husseini GA
Artif Cells Nanomed Biotechnol; 2018; 46(sup2):462-472. PubMed ID: 29644867
[TBL] [Abstract][Full Text] [Related]
7. Prolonged circulation time of doxorubicin-loaded liposomes coated with a modified polyvinyl alcohol after intravenous injection in rats.
Takeuchi H; Kojima H; Toyoda T; Yamamoto H; Hino T; Kawashima Y
Eur J Pharm Biopharm; 1999 Sep; 48(2):123-9. PubMed ID: 10469930
[TBL] [Abstract][Full Text] [Related]
8. Intratumor distribution of doxorubicin following i.v. administration of drug encapsulated in egg phosphatidylcholine/cholesterol liposomes.
Harasym TO; Cullis PR; Bally MB
Cancer Chemother Pharmacol; 1997; 40(4):309-17. PubMed ID: 9225948
[TBL] [Abstract][Full Text] [Related]
9. Direct comparison of liposomal doxorubicin with or without polyethylene glycol coating in C-26 tumor-bearing mice: is surface coating with polyethylene glycol beneficial?
Hong RL; Huang CJ; Tseng YL; Pang VF; Chen ST; Liu JJ; Chang FH
Clin Cancer Res; 1999 Nov; 5(11):3645-52. PubMed ID: 10589782
[TBL] [Abstract][Full Text] [Related]
10. Liposomes for targeting hepatocellular carcinoma: use of conjugated arabinogalactan as targeting ligand.
Shah SM; Goel PN; Jain AS; Pathak PO; Padhye SG; Govindarajan S; Ghosh SS; Chaudhari PR; Gude RP; Gopal V; Nagarsenker MS
Int J Pharm; 2014 Dec; 477(1-2):128-39. PubMed ID: 25311181
[TBL] [Abstract][Full Text] [Related]
11. Accumulation of liposomal lipid and encapsulated doxorubicin in murine Lewis lung carcinoma: the lack of beneficial effects by coating liposomes with poly(ethylene glycol).
Parr MJ; Masin D; Cullis PR; Bally MB
J Pharmacol Exp Ther; 1997 Mar; 280(3):1319-27. PubMed ID: 9067319
[TBL] [Abstract][Full Text] [Related]
12. Synthesis of novel tetravalent galactosylated DTPA-DSPE and study on hepatocyte-targeting efficiency in vitro and in vivo.
Xiao Y; Zhang H; Zhang Z; Yan M; Lei M; Zeng K; Zhao C
Int J Nanomedicine; 2013; 8():3033-50. PubMed ID: 23976853
[TBL] [Abstract][Full Text] [Related]
13. One platform comparison of estrone and folic acid anchored surface engineered MWCNTs for doxorubicin delivery.
Mehra NK; Jain NK
Mol Pharm; 2015 Feb; 12(2):630-43. PubMed ID: 25517904
[TBL] [Abstract][Full Text] [Related]
14. Design of Y-shaped targeting material for liposome-based multifunctional glioblastoma-targeted drug delivery.
Belhadj Z; Ying M; Cao X; Hu X; Zhan C; Wei X; Gao J; Wang X; Yan Z; Lu W
J Control Release; 2017 Jun; 255():132-141. PubMed ID: 28390902
[TBL] [Abstract][Full Text] [Related]
15. Enhanced delivery and antitumor activity of doxorubicin using long-circulating thermosensitive liposomes containing amphipathic polyethylene glycol in combination with local hyperthermia.
Unezaki S; Maruyama K; Takahashi N; Koyama M; Yuda T; Suginaka A; Iwatsuru M
Pharm Res; 1994 Aug; 11(8):1180-5. PubMed ID: 7971721
[TBL] [Abstract][Full Text] [Related]
16. PEGylated liposomal doxorubicin targeted to α5β1-expressing MDA-MB-231 breast cancer cells.
Shroff K; Kokkoli E
Langmuir; 2012 Mar; 28(10):4729-36. PubMed ID: 22268611
[TBL] [Abstract][Full Text] [Related]
17. Cell-penetrating Peptide-coated Liposomes for Drug Delivery Across the Blood-Brain Barrier.
Yuan BO; Zhao Y; Dong S; Sun Y; Hao F; Xie J; Teng L; Lee RJ; Fu Y; Bi YE
Anticancer Res; 2019 Jan; 39(1):237-243. PubMed ID: 30591464
[TBL] [Abstract][Full Text] [Related]
18. Prolonged blood circulation of methotrexate by modulation of liposomal composition.
Hong MS; Lim SJ; Lee MK; Kim YB; Kim CK
Drug Deliv; 2001; 8(4):231-7. PubMed ID: 11757781
[TBL] [Abstract][Full Text] [Related]
19. Liposomes with entrapped doxorubicin exhibit extended blood residence times.
Bally MB; Nayar R; Masin D; Hope MJ; Cullis PR; Mayer LD
Biochim Biophys Acta; 1990 Mar; 1023(1):133-9. PubMed ID: 2317492
[TBL] [Abstract][Full Text] [Related]
20. Modulation of doxorubicin resistance in multidrug-resistance cells by targeted liposomes combined with hyperthermia.
Gaber MH
J Biochem Mol Biol Biophys; 2002 Oct; 6(5):309-14. PubMed ID: 12385965
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
